Proprietary AI analyst is now available

Hi-Lex Valuation Multiples

Discover Hi-Lex's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Titan International, Monro, MIRAI, Lumax Industries and more.

Hi-Lex Overview

About Hi-Lex

Hi-Lex Corp is a Japanese company specialized in three segments: automobiles and industrial equipment, medical equipment, and a metal mold business. The automobiles equipment segment offers control cables, window regulators, sliding window systems, door modules, and others. The industrial equipment includes control boxes, steering systems, control cables for marine vessels, accelerator and assist cables for construction and industrial equipment, toilet seat elevators, and air conditioning grill raising and lowering systems for welfare and home.


Founded

1946

HQ

Japan

Employees

13.0K

Financials (LTM)

Revenue: $2B
Net Income: $54M

EV

$191M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Hi-Lex Financials

Hi-Lex reported last 12-month revenue of $2B.

In the same LTM period, Hi-Lex generated $54M in net income.

Revenue (LTM)


Hi-Lex P&L

In the most recent fiscal year, Hi-Lex reported revenue of $2B and EBITDA of $132M.

Hi-Lex is profitable as of last fiscal year, with gross margin of 11%, EBITDA margin of 7%, and net margin of 3%.

See analyst estimates for Hi-Lex
LTMLast FY202320242025202620272028
Revenue$2B$2B$2B$2B$2B
Gross Profit-$210M$194M$195M$210M
Gross Margin-11%10%10%11%
EBITDA-$132M$65M$108M$132M
EBITDA Margin-7%3%6%7%
EBIT Margin1%1%1%0%1%
Net Profit$54M$54M($13M)$19M$52M
Net Margin3%3%(1%)1%3%

Financial data powered by Morningstar, Inc.

Hi-Lex Stock Performance

Hi-Lex has current market cap of $475M, and enterprise value of $191M.

Market Cap Evolution


Hi-Lex's stock price is $12.86.

Hi-Lex share price decreased by 17.4% in the last 30 days.

Hi-Lex has an EPS (earnings per share) of $1.46.

See more trading valuation data for Hi-Lex
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$191M$475M-3.0%-17.4%--$1.46

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Hi-Lex Valuation Multiples

Hi-Lex trades at 0.1x EV/Revenue multiple, and 1.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Hi-Lex

EV / Revenue (LTM)


Hi-Lex Financial Valuation Multiples

As of June 24, 2026, Hi-Lex has market cap of $475M and EV of $191M.

Hi-Lex has a P/E ratio of 8.8x.

LTMLast FY202320242025202620272028
EV/Revenue0.1x0.1x0.1x0.1x0.1x
EV/EBITDA-1.5x3.0x1.8x1.5x
EV/EBIT8.8x8.8x12.1x35.5x9.1x
EV/Gross Profit-0.9x1.0x1.0x0.9x
P/E8.8x8.8x(35.5x)25.2x9.1x
EV/FCF-9.5x4.9x25.0x9.5x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Hi-Lex Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Hi-Lex Margins & Growth Rates

In the most recent fiscal year, Hi-Lex reported gross margin of 11%, EBITDA margin of 7%, and net margin of 3%.

See estimated margins and future growth rates for Hi-Lex

Hi-Lex Margins

Last FY20242025202720282029
Gross Margin11%10%11%
EBITDA Margin7%6%7%
EBIT Margin1%0%1%
Net Margin3%1%3%
FCF Margin1%0%1%

Hi-Lex Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth2%(1%)
Gross Profit Growth0%8%
EBITDA Growth67%22%
EBIT Growth(66%)290%
Net Profit Growth(241%)176%
FCF Growth(80%)162%

Data powered by FactSet, Inc. and Morningstar, Inc.

Hi-Lex Operational KPIs

Hi-Lex's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Hi-Lex
Last FY202320242025202620272028
Revenue per Employee$0.1M---
Opex per Employee$0.0M---
Opex to Revenue10%10%10%10%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Hi-Lex Competitors

Hi-Lex competitors include Titan International, Monro, MIRAI, Lumax Industries, Turners Automotive Group, Cooper-Standard Holdings, ECARX Group, Wabash National, MEKO and Zaptec.

Most Hi-Lex public comparables operate across Automotive Parts.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Titan International0.6x0.6x10.2x9.8x
Monro0.8x0.8x10.0x10.1x
MIRAI11.8x22.1x21.8x21.8x
Lumax Industries1.4x1.3x12.7x13.5x
Turners Automotive Group5.0x2.7x13.6x-
Cooper-Standard Holdings0.6x0.6x7.8x7.0x
ECARX Group1.0x0.9x(43.8x)159.4x
Wabash National0.6x0.6x2.7x(90.5x)

This data is available for Pro users. Sign up to see all Hi-Lex competitors and their valuation data.

Start Free Trial

Investments by Hi-Lex

Hi-Lex has invested in 1 company to date.

Latest investment by Hi-Lex was on December 25th 2019. Hi-Lex invested in INNOPHYS in their $32M Series C round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Hi-Lex

INNOPHYS
Description
INNOPHYS is a Kawasaki-based robotics firm developing wearable exoskeletons like the Muscle Suit for industrial and elderly care. Launched in 2015, the pneumatic artificial muscle device reduces back strain during lifting tasks up to 20 kg. Distributed in Japan, it targets manufacturing and construction sectors with expansions into Asia and Europe.
HQ CountryJapan
HQ City
Tokyo
Deal Date25 Dec 2019
RoundSeries C
Raised$32M
InvestorsHi-Lex; TOKAI; TIS Japan; Fidelity International; BIC Camera; Brother; NAC; Future Venture Capital; TOWA Pharmaceutical
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Hi-Lex investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Hi-Lex

See public comps similar to Hi-Lex

Lists including Hi-Lex

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial